Key result
Combination therapy with midodrine, fludrocortisone, and droxidopa failed to fully resolve refractory orthostatic hypotension in an 82-year-old male, demonstrating the complexity of managing autonomic dysautonomia.
Why the study?
Orthostatic hypotension commonly affects the elderly and can be challenging to manage, warranting discussion of current medical therapies and pathophysiology.
Case Report (n=1)
No
Management of refractory orthostatic hypotension is challenging and requires individualized combination therapy while monitoring for adverse effects like supine hypertension.
Answers are grounded in this paper and cite their sources.
Refractory orthostatic hypotension may persist despite triple therapy; leaves open need for individualized strategies in autonomic failure.
Orthostatic hypotension (OH) commonly affects the elderly and can be challenging to manage. Its symptomology can be variable and is induced by decreased cerebral perfusion. Here, we present a complex yet compelling case of a patient with refractory OH, focusing on delineating current medical therapies and pathophysiology for in-training medical professionals.
No takes yet. Share an insight, caveat, or question.
Memon et al. (2022) conducted a case report in Refractory orthostatic hypotension (n=1). Midodrine, fludrocortisone, and droxidopa was evaluated on Orthostatic hypotension symptomatology and blood pressure. Combination therapy with midodrine, fludrocortisone, and droxidopa failed to fully resolve refractory orthostatic hypotension in an 82-year-old male, demonstrating the complexity of managing autonomic dysautonomia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: